Myvideo

Guest

Login

CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatment

Uploaded By: Myvideo
1 view
0
0 votes
0
AboutShareDownloadAdd to

Samarth Kulkarni, CRISPR Therapeutics CEO, joins ’Closing Bell Overtime’ to talk winning FDA approval in the U.S. for sickle cell treatment in partnership with Vertex.

Share with your friends

Link:

Embed:

Video Size:

Custom size:

x
Share this video

Copy Link:

Google Plus

Add to Playlist:

Favorites
My Playlist
Watch Later
Add to
Favorites
My Playlist
Watch Later
Similar VideosComments
Журнальный клуб НЦН 25 сентября 2024 г.Watch Video
5 months ago
00:39:17
Журнальный клуб НЦН 25 сентября 2024 г.
17 84%
FDA approves gene-editing therapy for sickle cell diseaseWatch Video
1 year ago
00:07:16
FDA approves gene-editing therapy for sickle cell disease
1 24%
CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatmentWatch Video
1 year ago
00:05:27
CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatment
1 46%
( )Watch Video
1 year ago
00:00:04
( )
1 13%
FuturologyWatch Video
4 years ago
00:08:35
Futurology
1 5%
0 Comments
Guest